SCHEMBL6978588

SCHEMBL6978588

O=C(c1ccc2c(c1)CCCN2)N1CCOCC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
MAPT P10636 1/20 0.59
PKM P14618 1/20 0.51
HPGD P15428 5/20 0.49
PHGDH O43175 1/20 0.48
CRBN Q96SW2 1/20 0.47
HSP90AA1 P07900 2/20 0.46
HSP90AB1 P08238 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 3/20 0.45
CNR1 P21554 1/20 0.45
GLA P06280 1/20 0.45
POLB P06746 1/20 0.45
DNMT1 P26358 1/20 0.45
PTPN7 P35236 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MASP2 O00187 1/20 0.45
F2 P00734 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15897866 0.92 CRBN (0.55) KDM4EMAPTPKMHPGDPHGDH
SCHEMBL6982244 0.88 KDM4E (0.64) KDM4EMAPTHPGDCRBNALDH1A1
SCHEMBL30031951 0.86 MAPT (0.58) KDM4EMAPTHPGDCRBNALDH1A1
SCHEMBL6976973 0.82 KDM4E (0.57) KDM4EMAPTHPGDCRBNALDH1A1
SCHEMBL30226880 0.82 CRBN (0.58) KDM4EMAPTHPGDCRBNALDH1A1
SCHEMBL15898298 0.81 CRBN (0.55) KDM4EPKMHPGDPHGDHCRBN
SCHEMBL22226394 0.81 CRBN (0.57) KDM4EMAPTHPGDCRBNALDH1A1
SCHEMBL30226900 0.81 CRBN (0.57) KDM4EMAPTHPGDCRBNALDH1A1
SCHEMBL7325238 0.79 CRBN (0.58) PKMHPGDPHGDHCRBNHSP90AA1
SCHEMBL6980782 0.77 KDM4E (0.60) KDM4EMAPTHPGDCRBNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed